Filing Details
- Accession Number:
- 0001104659-24-098940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 16:30:08
- Reporting Period:
- 2024-09-09
- Accepted Time:
- 2024-09-11 16:30:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1671502 | Quoin Pharmaceuticals Ltd. | QNRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1958139 | Gordon Dunn | C/O Quoin Pharmaceuticals Ltd. 42127 Pleasant Forest Court Ashburn VA 20148 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2024-09-09 | 856 | $0.80 | 856 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2024-09-09 | 4,000 | $0.78 | 4,856 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2024-09-09 | 4,000 | $0.80 | 8,856 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2024-09-10 | 10,000 | $0.91 | 18,856 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2024-09-10 | 10,000 | $0.71 | 28,856 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer.